LS
ABBV icon

Leelyn Smith’s AbbVie ABBV Stock Holding History

Leelyn Smith’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93M Buy
19,606
+425
+2% +$91.4K 0.6% 46
2026
Q1 		$4.17M Buy
19,181
+587
+3% +$130K 0.59% 48
2025
Q4 		$4.25M Sell
18,594
-821
-4% -$187K 0.61% 44
2025
Q3 		$4.5M Buy
19,415
+1,209
+7% +$246K 0.68% 35
2025
Q2 		$3.38M Buy
18,206
+299
+2% +$55.6K 0.55% 43
2025
Q1 		$3.75M Sell
17,907
-345
-2% -$67.1K 0.67% 40
2024
Q4 		$3.24M Sell
18,252
-338
-2% -$62.1K 0.58% 43
2024
Q3 		$3.67M Sell
18,590
-29
-0.2% -$5.41K 0.66% 41
2024
Q2 		$3.19M Sell
18,619
-597
-3% -$98.9K 0.62% 43
2024
Q1 		$3.5M Sell
19,216
-457
-2% -$78.8K 0.7% 42
2023
Q4 		$3.05M Sell
19,673
-548
-3% -$79.9K 0.67% 42
2023
Q3 		$3.01M Sell
20,221
-482
-2% -$70.8K 0.74% 38
2023
Q2 		$2.79M Sell
20,703
-898
-4% -$132K 0.67% 42
2023
Q1 		$3.44M Sell
21,601
-71
-0.3% -$10.9K 0.88% 29
2022
Q4 		$3.5M Buy
21,672
+843
+4% +$129K 0.96% 23
2022
Q3 		$2.79M Sell
20,829
-439
-2% -$63K 0.97% 22
2022
Q2 		$3.26M Sell
21,268
-552
-3% -$84.3K 0.84% 33
2022
Q1 		$3.54M Sell
21,820
-7
-0% -$1.02K 0.92% 24
2021
Q4 		$2.96M Sell
21,827
-707
-3% -$83.5K 0.79% 32
2021
Q3 		$2.43M Buy
22,534
+141
+0.6% +$16.1K 0.7% 39
2021
Q2 		$2.52M Sell
22,393
-113
-0.5% -$12.7K 0.74% 39
2021
Q1 		$2.44M Buy
22,506
+754
+3% +$80.7K 0.73% 37
2020
Q4 		$2.33M Buy
21,752
+401
+2% +$38.5K 0.75% 35
2020
Q3 		$1.87M Sell
21,351
-134
-0.6% -$12.6K 0.66% 38
2020
Q2 		$2.11M Sell
21,485
-414
-2% -$36.5K 0.87% 23
2020
Q1 		$1.6M Buy
21,899
+2,353
+12% +$200K 0.85% 29
2019
Q4 		$1.73K Buy
+19,546
New +$1.62M 0.83% 26

Other funds holding ABBV

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Leelyn Smith's ABBV Position: Q2 2026 in Review

Leelyn Smith increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $91.4K and bringing the position to 19,606 shares worth $4.93M. The position accounts for 0.6% of the portfolio, ranked #46.

Leelyn Smith first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Leelyn Smith held 19,606 shares of AbbVie worth $4.93M as of Q2 2026.
  • Leelyn Smith bought 425 AbbVie shares in Q2 2026, an estimated $91.4K.
  • AbbVie made up 0.6% of Leelyn Smith's portfolio in Q2 2026, its #46 holding.
  • Leelyn Smith first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.